Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings
| Author | Affiliation | ||
|---|---|---|---|
Magliano, Dianna J | Baker Heart and Diabetes Institute | Monash University | |
Chen, Lei | Baker Heart and Diabetes Institute | ||
Islam, Rakibul M | Monash University | ||
Carstensen, Bendix | Steno Diabetes Center Copenhagen | ||
Gregg, Edward W | Imperial College London | ||
Pavkov, Meda E | Centers for Disease Control and Prevention | ||
Andes, Linda J | Centers for Disease Control and Prevention | ||
Balicer, Ran | Clalit Health Services | ||
Baviera, Marta | Mario Negri Institute for Pharmacological Research IRCCS | ||
Boersma-van Dam, Elise | Netherlands Institute for Health Services Research | ||
Booth, Gillian L | University of Toronto | ||
Chan, Juliana C N | Chinese University of Hong Kong | ||
Chua, Yi Xian | Public Health Group | ||
Fosse-Edorh, Sandrine | Santé Publique France | ||
Fuentes, Sonsoles | Santé Publique France | ||
Gulseth, Hanne L | Norwegian Institute of Public Health | ||
Higienos institutas | |||
Ha, Kyoung Hwa | Ajou University School of Medicine | ||
Hird, Thomas R | Baker Heart and Diabetes Institute | Monash University | |
Jermendy, György | Bajcsy-Zsilinszky Hospital | ||
Khalangot, Mykola D | National Academy of Medical Sciences | Shupyk National Medical Academy of Postgraduate Education | |
Kim, Dae Jung | Ajou University School of Medicine | ||
Kiss, Zoltán | University of Pécs | ||
Kravchenko, Victor I | National Academy of Medical Sciences | ||
Leventer-Roberts, Maya | Clalit Health Services | Icahn School of Medicine at Mount Sinai | |
Lin, Chun-Yi | Taipei Veterans General Hospital | ||
Luk, Andrea O Y | Chinese University of Hong Kong | ||
Mata-Cases, Manel | Instituto de Salud Carlos III | Institut Universitari dInvestigació en Atenció Primària Jordi Gol | |
Mauricio, Didac | Instituto de Salud Carlos III | Institut Universitari dInvestigació en Atenció Primària Jordi Gol | Autonomous University of Barcelona |
Nichols, Gregory A | Kaiser Permanente Center for Health Research | ||
Nielen, Mark M | Netherlands Institute for Health Services Research | ||
Pang, Deanette | Public Health Group | ||
Paul, Sanjoy K | University of Melbourne | ||
Pelletier, Catherine | Public Health Agency of Canada | ||
Pildava, Santa | Centre for Disease Prevention and Control | ||
Porath, Avi | Maccabi Healthcare Services | Ben Gurion University | |
Read, Stephanie H | University of Edinburgh | ||
Roncaglioni, Maria Carla | Mario Negri Institute for Pharmacological Research IRCCS | ||
Lopez-Doriga Ruiz, Paz | Norwegian Institute of Public Health | Oslo University Hospital | |
Shestakova, Marina | Endocrinology Research Center | ||
Vikulova, Olga | Endocrinology Research Center | ||
Wang, Kang-Ling | Taipei Veterans General Hospital | ||
Wild, Sarah H | University of Edinburgh | ||
Yekutiel, Naama | Maccabi Healthcare Services | ||
Shaw, Jonathan E | Baker Heart and Diabetes Institute | Monash University | Latrobe University |
Elsevier. Lancet Publishing Group |
| Date |
|---|
2021 |
Background: Diabetes prevalence is increasing in most places in the world, but prevalence is affected by both risk of developing diabetes and survival of those with diabetes. Diabetes incidence is a better metric to understand the trends in population risk of diabetes. Using a multicountry analysis, we aimed to ascertain whether the incidence of clinically diagnosed diabetes has changed over time. Methods: In this multicountry data analysis, we assembled aggregated data describing trends in diagnosed total or type 2 diabetes incidence from 24 population-based data sources in 21 countries or jurisdictions. Data were from administrative sources, health insurance records, registries, and a health survey. We modelled incidence rates with Poisson regression, using age and calendar time (1995–2018) as variables, describing the effects with restricted cubic splines with six knots for age and calendar time. Findings: Our data included about 22 million diabetes diagnoses from 5 billion person-years of follow-up. Data were from 19 high-income and two middle-income countries or jurisdictions. 23 data sources had data from 2010 onwards, among which 19 had a downward or stable trend, with an annual estimated change in incidence ranging from −1·1% to −10·8%. Among the four data sources with an increasing trend from 2010 onwards, the annual estimated change ranged from 0·9% to 5·6%. The findings were robust to sensitivity analyses excluding data sources in which the data quality was lower and were consistent in analyses stratified by different diabetes definitions. Interpretation: The incidence of diagnosed diabetes is stabilising or declining in many high-income countries. The reasons for the declines in the incidence of diagnosed diabetes warrant further investigation with appropriate data sources. Funding: US Centers for Disease Control and Prevention, Diabetes Australia Research Program, and Victoria State Government Operational Infrastructure Support Program.
| Journal | IF | AIF | AIF (min) | AIF (max) | Cat | AV | Year | Quartile |
|---|---|---|---|---|---|---|---|---|
Lancet Diabetes & Endocrinology | 44.867 | 5.79 | 5.79 | 5.79 | 1 | 7.749 | 2021 | Q1 |
| Journal | Cite Score | SNIP | SJR | Year | Quartile |
|---|---|---|---|---|---|
The Lancet Diabetes and Endocrinology | 49.2 | 8.999 | 9.767 | 2021 | Q1 |